Company profile for Celgene Corporation

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgen...
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
86 Morris Avenue, Summit, NJ 07901
Telephone
Telephone
+1 (908) 673 9000
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercepharma.com/pharma/bms-skates-again-64b-celgene-shareholder-lawsuit-still-not-free-another-filing

FIERCE PHARMA
02 Oct 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761136

FDA
16 May 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/bristol-myers-bowel-disease-drug-fails-meet-main-goal-late-stage-study-2024-03-28/

REUTERS
29 Mar 2024

https://recalls-rappels.canada.ca/en/alert-recall/istodax-romidepsin-restricted-access-program

HEALTH CANADA
20 Mar 2023

https://www.reuters.com/legal/bristol-myers-wins-dismissal-lawsuit-over-celgene-drugs-2023-03-01/

REUTERS
02 Mar 2023

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharma-gets-usfda-nod-to-market-generic-medication/articleshow/97795222.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMIC TIMES
10 Feb 2023

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Celgene Corporation and get a quotation

Celgene Corporation is a supplier offers 4 products (APIs, Excipients or Intermediates).

Find a price of Marizomib bulk offered by Celgene Corporation

Find a price of Romidepsin bulk offered by Celgene Corporation

Find a price of Lenalidomide bulk offered by Celgene Corporation

Find a price of Thalidomide bulk offered by Celgene Corporation

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty